Metastatic Castration-Resistant Prostate Cancer Therapeutics Market Size, Share & Industry Analysis, By Drug Class (Androgen Receptor Inhibitors, Microtubule Inhibitors, Gonadotropin Releasing Hormone (GnRH) Agonist, Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist, and Others), By Route of Administration (Oral and Parenteral), By Therapy (Chemotherapy, Hormonal Therapy, Targeted Therapy, and Immunotherapy), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2026-2034

Billing Details

Captcha refresh

Continue for Payment Method

Pay with Strip
Total: $ 4850